世界の黒色腫がん市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV12639)
◆英語タイトル:Global Melanoma Cancer Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV12639
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:97
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは黒色腫がんの世界市場について調査・分析した資料です。種類別(非浸潤性黒色腫、浸潤性黒色腫)の市場規模、用途別(病院、がん研究センター)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別黒色腫がんの競争状況、市場シェア
・世界の黒色腫がん市場:種類別市場規模 2015年-2020年(非浸潤性黒色腫、浸潤性黒色腫)
・世界の黒色腫がん市場:種類別市場規模予測 2021年-2026年(非浸潤性黒色腫、浸潤性黒色腫)
・世界の黒色腫がん市場:用途別市場規模 2015年-2020年(病院、がん研究センター)
・世界の黒色腫がん市場:用途別市場規模予測 2021年-2026年(病院、がん研究センター)
・北米の黒色腫がん市場分析:米国、カナダ
・ヨーロッパの黒色腫がん市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの黒色腫がん市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の黒色腫がん市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの黒色腫がん市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):AB Sciences、Incyte、Merck、Novartis、Pierre Fabre、Amgen、AstraZeneca、Bristol-Myers Squibb、Daiichi Sankyo
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Melanoma Cancer is a skin cancer that develops due to expose of UV rays on the skin.
Increasing incidence of melanoma across the globe and rising ozone layer depletion due to global warming are the major factors that are driving the market during the forecast period. Additionally, overexposure to radiation during certain treatments or exposure to chemicals during working, increasing awareness about cancer, and rising healthcare expenditure is also motivating the market.

Market Analysis and Insights: Global Melanoma Cancer Market
The global Melanoma Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Melanoma Cancer Scope and Market Size
Melanoma Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Melanoma Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
AB Sciences
Incyte
Merck
Novartis
Pierre Fabre
Amgen
AstraZeneca
Bristol-Myers Squibb
Daiichi Sankyo

Market segment by Type, the product can be split into
Non-invasive melanoma
Invasive melanoma
Market segment by Application, split into
Hospitals
Cancer Research Centers

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Melanoma Cancer Revenue
1.4 Market by Type
1.4.1 Global Melanoma Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Non-invasive melanoma
1.4.3 Invasive melanoma
1.5 Market by Application
1.5.1 Global Melanoma Cancer Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Cancer Research Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Melanoma Cancer Market Perspective (2015-2026)
2.2 Global Melanoma Cancer Growth Trends by Regions
2.2.1 Melanoma Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Melanoma Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Melanoma Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Melanoma Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Melanoma Cancer Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Melanoma Cancer Players by Market Size
3.1.1 Global Top Melanoma Cancer Players by Revenue (2015-2020)
3.1.2 Global Melanoma Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global Melanoma Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Melanoma Cancer Market Concentration Ratio
3.2.1 Global Melanoma Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Melanoma Cancer Revenue in 2019
3.3 Melanoma Cancer Key Players Head office and Area Served
3.4 Key Players Melanoma Cancer Product Solution and Service
3.5 Date of Enter into Melanoma Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Melanoma Cancer Historic Market Size by Type (2015-2020)
4.2 Global Melanoma Cancer Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Melanoma Cancer Market Size by Application (2015-2020)
5.2 Global Melanoma Cancer Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Melanoma Cancer Market Size (2015-2020)
6.2 Melanoma Cancer Key Players in North America (2019-2020)
6.3 North America Melanoma Cancer Market Size by Type (2015-2020)
6.4 North America Melanoma Cancer Market Size by Application (2015-2020)

7 Europe
7.1 Europe Melanoma Cancer Market Size (2015-2020)
7.2 Melanoma Cancer Key Players in Europe (2019-2020)
7.3 Europe Melanoma Cancer Market Size by Type (2015-2020)
7.4 Europe Melanoma Cancer Market Size by Application (2015-2020)

8 China
8.1 China Melanoma Cancer Market Size (2015-2020)
8.2 Melanoma Cancer Key Players in China (2019-2020)
8.3 China Melanoma Cancer Market Size by Type (2015-2020)
8.4 China Melanoma Cancer Market Size by Application (2015-2020)

9 Japan
9.1 Japan Melanoma Cancer Market Size (2015-2020)
9.2 Melanoma Cancer Key Players in Japan (2019-2020)
9.3 Japan Melanoma Cancer Market Size by Type (2015-2020)
9.4 Japan Melanoma Cancer Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Melanoma Cancer Market Size (2015-2020)
10.2 Melanoma Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Melanoma Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Melanoma Cancer Market Size by Application (2015-2020)

11 India
11.1 India Melanoma Cancer Market Size (2015-2020)
11.2 Melanoma Cancer Key Players in India (2019-2020)
11.3 India Melanoma Cancer Market Size by Type (2015-2020)
11.4 India Melanoma Cancer Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Melanoma Cancer Market Size (2015-2020)
12.2 Melanoma Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Melanoma Cancer Market Size by Type (2015-2020)
12.4 Central & South America Melanoma Cancer Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 AB Sciences
13.1.1 AB Sciences Company Details
13.1.2 AB Sciences Business Overview
13.1.3 AB Sciences Melanoma Cancer Introduction
13.1.4 AB Sciences Revenue in Melanoma Cancer Business (2015-2020))
13.1.5 AB Sciences Recent Development
13.2 Incyte
13.2.1 Incyte Company Details
13.2.2 Incyte Business Overview
13.2.3 Incyte Melanoma Cancer Introduction
13.2.4 Incyte Revenue in Melanoma Cancer Business (2015-2020)
13.2.5 Incyte Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Melanoma Cancer Introduction
13.3.4 Merck Revenue in Melanoma Cancer Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Melanoma Cancer Introduction
13.4.4 Novartis Revenue in Melanoma Cancer Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Pierre Fabre
13.5.1 Pierre Fabre Company Details
13.5.2 Pierre Fabre Business Overview
13.5.3 Pierre Fabre Melanoma Cancer Introduction
13.5.4 Pierre Fabre Revenue in Melanoma Cancer Business (2015-2020)
13.5.5 Pierre Fabre Recent Development
13.6 Amgen
13.6.1 Amgen Company Details
13.6.2 Amgen Business Overview
13.6.3 Amgen Melanoma Cancer Introduction
13.6.4 Amgen Revenue in Melanoma Cancer Business (2015-2020)
13.6.5 Amgen Recent Development
13.7 AstraZeneca
13.7.1 AstraZeneca Company Details
13.7.2 AstraZeneca Business Overview
13.7.3 AstraZeneca Melanoma Cancer Introduction
13.7.4 AstraZeneca Revenue in Melanoma Cancer Business (2015-2020)
13.7.5 AstraZeneca Recent Development
13.8 Bristol-Myers Squibb
13.8.1 Bristol-Myers Squibb Company Details
13.8.2 Bristol-Myers Squibb Business Overview
13.8.3 Bristol-Myers Squibb Melanoma Cancer Introduction
13.8.4 Bristol-Myers Squibb Revenue in Melanoma Cancer Business (2015-2020)
13.8.5 Bristol-Myers Squibb Recent Development
13.9 Daiichi Sankyo
13.9.1 Daiichi Sankyo Company Details
13.9.2 Daiichi Sankyo Business Overview
13.9.3 Daiichi Sankyo Melanoma Cancer Introduction
13.9.4 Daiichi Sankyo Revenue in Melanoma Cancer Business (2015-2020)
13.9.5 Daiichi Sankyo Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

AB Sciences、Incyte、Merck、Novartis、Pierre Fabre、Amgen、AstraZeneca、Bristol-Myers Squibb、Daiichi Sankyo

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の黒色腫がん市場2026:インサイト・予測(Global Melanoma Cancer Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。